51 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
9 Aug 18
Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
4:07pm
of 2017. The increase was primarily due to $1.5 million in employee-related costs due to the hiring of additional personnel during the past year … . The increase was primarily due to a $1.3 million increase in employee-related costs attributable to hiring additional personnel to support Rhythm’s growing
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Nov 19
Rhythm Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:22pm
of $1.5 million due to the hiring of additional personnel related to community building and education efforts for physicians, care providers … with the hiring of additional full-time employees to support planned commercial activities, operations and the continued build of finance and human resource
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
9 Nov 18
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
12:40pm
was primarily due to $1.3 million in employee related costs due to the hiring of additional personnel during the second half of 2017 and throughout 2018 … to hiring additional personnel to enable the Company’s growth, an increase of $4.0 million for patient identification programs, and consulting services
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
pharmaceutical ingredient (API) for clinical trials and commercial scale up and pre-IND work for RM-853; and an increase of $2.3 million due to the hiring … and commercial scale up and pre-IND work for RM-853; and an increase of $4.7 million in employee-related costs due to the hiring of additional
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
8 Mar 19
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:04pm
in employee-related costs due to the hiring of additional personnel throughout 2018; an increase of $5.0 million related to ongoing clinical trials … commercial launch of setmelanotide; an increase of $4.4 million in employee-related costs due to the hiring of additional personnel to support planned
8-K
EX-99.1
ce504s5oh
3 Aug 21
Rhythm Pharmaceuticals Reports Second Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
lm7nok 4tm7
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am
8-K
EX-99.1
z5rz 37tep670zl1rz
2 Nov 21
Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
dvcd4ot77l j0k7i4yo
3 May 19
Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results
5:08pm
8-K
EX-99.1
ovtyz7gc9hg7 k4z
14 May 18
Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
4:01pm
8-K
EX-99.1
uuwr1y0 ki9
2 Mar 20
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
4:51pm
8-K
EX-99.1
pcu4bz2xzuxf3s8g38
1 Mar 21
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
9:01am
8-K
EX-99.1
640n99w35mvtb
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
8-K
EX-99.1
s63eegm rb
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
EX-99.1
1r81qz85 x1
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am